Treatment utilization among persons with opioid use disorder in the United States.

dc.contributor.author

Wu, Li-Tzy

dc.contributor.author

Zhu, He

dc.contributor.author

Swartz, Marvin S

dc.coverage.spatial

Ireland

dc.date.accessioned

2016-12-01T18:43:40Z

dc.date.issued

2016-12-01

dc.description.abstract

BACKGROUND: The United States is experiencing an opioid overdose epidemic. Treatment use data from diverse racial/ethnic groups with opioid use disorder (OUD) are needed to inform treatment expansion efforts. METHODS: We examined demographic characteristics and behavioral health of persons aged ≥12 years that met criteria for past-year OUD (n=6,125) in the 2005-2013 National Surveys on Drug Use and Health (N=503,101). We determined the prevalence and correlates of past-year use of alcohol/drug use treatment and opioid-specific treatment to inform efforts for improving OUD treatment. RESULTS: Among persons with OUD, 81.93% had prescription (Rx) OUD only, 9.75% had heroin use disorder (HUD) only, and 8.32% had Rx OUD+HUD. Persons with Rx OUD+HUD tended to be white, adults aged 18-49, males, or uninsured. The majority (80.09%) of persons with OUD had another substance use disorder (SUD), and major depressive episode (MDE) was common (28.74%). Of persons with OUD, 26.19% used any alcohol or drug use treatment, and 19.44% used opioid-specific treatment. Adolescents, the uninsured, blacks, native-Hawaiians/Pacific-Islanders/Asian-Americans, persons with Rx OUD only, and persons without MDE or SUD particularly underutilized opioid-specific treatment. Among alcohol/drug use treatment users, self-help group and outpatient rehabilitation treatment were commonly used services. CONCLUSIONS: Most people with OUD report no use of OUD treatment. Multifaceted interventions, including efforts to access insurance coverage, are required to change attitudes and knowledge towards addiction treatment in order to develop a supportive culture and infrastructure to enable treatment-seeking. Outreach efforts could target adolescents, minority groups, and the uninsured to improve access to treatment.

dc.identifier

http://www.ncbi.nlm.nih.gov/pubmed/27810654

dc.identifier

S0376-8716(16)30950-4

dc.identifier.eissn

1879-0046

dc.identifier.uri

https://hdl.handle.net/10161/13080

dc.language

eng

dc.publisher

Elsevier BV

dc.relation.ispartof

Drug Alcohol Depend

dc.relation.isversionof

10.1016/j.drugalcdep.2016.10.015

dc.subject

Heroin use disorder

dc.subject

Medication-assisted treatment

dc.subject

Opioid use disorder

dc.subject

Prescription opioid misuse

dc.subject

Substance use treatment

dc.title

Treatment utilization among persons with opioid use disorder in the United States.

dc.type

Journal article

duke.contributor.orcid

Wu, Li-Tzy|0000-0002-5909-2259

pubs.author-url

http://www.ncbi.nlm.nih.gov/pubmed/27810654

pubs.begin-page

117

pubs.end-page

127

pubs.organisational-group

Center for Child and Family Policy

pubs.organisational-group

Clinical Science Departments

pubs.organisational-group

Duke

pubs.organisational-group

Duke Clinical Research Institute

pubs.organisational-group

Duke Institute for Brain Sciences

pubs.organisational-group

Institutes and Centers

pubs.organisational-group

Institutes and Provost's Academic Units

pubs.organisational-group

Medicine

pubs.organisational-group

Medicine, General Internal Medicine

pubs.organisational-group

Psychiatry & Behavioral Sciences

pubs.organisational-group

Psychiatry & Behavioral Sciences, Social and Community Psychiatry

pubs.organisational-group

Sanford School of Public Policy

pubs.organisational-group

School of Medicine

pubs.organisational-group

University Institutes and Centers

pubs.publication-status

Published

pubs.volume

169

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
Wu DAD OUD_TX 2016 published.pdf
Size:
600.66 KB
Format:
Adobe Portable Document Format
Description:
Published version